胃食道循环瘤细胞与外周免疫系统的交叉交叉指导CTC生存和增殖
Tania Rossi1, Martina Valgiusti2, Maurizio Puccetti3
1Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
Cell death & disease
|March 29, 2025
概括
免疫系统有助于循环瘤细胞 (CTC) 的生存和通过细胞外囊泡 (EV) 传播. 这项研究开发了一个共同培养系统来产生CTC细胞系,揭示了免疫逃避机制.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 瘤传播涉及循环瘤细胞 (CTC) 和免疫细胞,但免疫系统在CTC存活中的作用尚不清楚.
- 了解CTC-免疫细胞相互作用对于癌症进展研究至关重要.
研究的目的:
- 建立一个体外共同培养系统,以产生长期的CTC衍生细胞系.
- 研究免疫细胞信号及其对CTC增殖和生存的影响.
主要方法:
- 开发了一种体外共同培养系统,使用患者衍生的免疫细胞和CTC.
- 描述了四个胃食道CTC细胞系的遗传,分子和转录基因特征.
- 评估了斑马鱼的侵入性,并分析了细胞外囊泡 (EV) 含量.
主要成果:
- 成功建立了四个转移性胃食道CTC细胞系与共享的染色体异常 (MYC放大,CDKN2A/B删除).
- CTC细胞系表现出明显的转录组形状,具有激活的E2F,G2M和MYC通路,以及下调的干扰素反应.
- 由CTCs分泌的EV含有针对关键癌症途径的microRNA,侵入性与RAB14基因突变相关.
结论:
- 通过EV信号传递,免疫系统显著促进CTC的扩散.
- 在CTC中的基因组和转录基因组变化有助于免疫逃避和生存优势.
- 共同培养系统为研究CTC-免疫细胞相互作用提供了有价值的工具.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


